Kura Oncology Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good afternoon, everybody. Thank you for joining us today. On behalf of the entire JPMorgan Healthcare team, it is my pleasure to introduce you to Troy Wilson, President and CEO of Kura Oncology. Just as a friendly reminder, you may submit your questions through the ask a Q feature listed under the presentation. Thank you for your participation. And I'll now hand it off to Troy. Thank you again.
Thank you, [Amy], and thank you to our colleagues at JPMorgan for the invitation to present in today's conference. It's unfortunate that we're not able to see many of you in person, but we're going to do the best we can today and give you an update on all of the progress that we've been making at Kura Oncology over the last year and to look forward to what you'll see in 2021 and beyond. And again, I want to thank JPMorgan for this opportunity.
I'm going to be calling out slide numbers for those of you who are following along. And so we'll start with just a quick forward
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |